SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-21-009662
Filing Date
2021-04-23
Accepted
2021-04-23 09:29:20
Documents
9
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A acrx20210416_def14a.htm DEF 14A 1156678
2 image01.jpg GRAPHIC 8073
3 image02.jpg GRAPHIC 6584
4 image03.jpg GRAPHIC 9588
5 image04.jpg GRAPHIC 11584
6 image05.jpg GRAPHIC 16086
7 image06.jpg GRAPHIC 15988
8 proxy01.jpg GRAPHIC 146752
9 proxy02.jpg GRAPHIC 111427
  Complete submission text file 0001437749-21-009662.txt   1607261
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35068 | Film No.: 21846957
SIC: 2834 Pharmaceutical Preparations